Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.

Autor Tai-Kuang Chao, Tien-Shuo Huang, Yu-Ping Liao, Rui-Lan Huang, Po-Hsuan Su, Hueng-Yuan Shen, Hung-Cheng Lai, Yu-Chi Wang
Vydáno 2017-01-01

<i>Pyruvate Kinase M2</i> Expression: A Potential Metabolic Biomarker to Differentiate Endometrial Precancer and Cancer That Is Associated with Poor Outcomes in Endometrial Carcino...

Autor Yu-Ju Lai, Yu-Ching Chou, Yi-Jia Lin, Mu-Hsien Yu, Yu-Che Ou, Po-Wei Chu, Chia-Chun Wu, Yu-Chi Wang, Tai-Kuang Chao
Vydáno 2019-11-01